December 15th 2021
A personal history of cervical cancer or cervical biopsy did not make mothers more likely to vaccinate their children against HPV.
December 13th 2021
HPV vaccination decreases cervical cancer incidence and mortality, but it is most effective in young women and girls.
November 16th 2021
States with policy that permitted adolescents to independently choose to receive HPV vaccination had a significantly higher immunization uptake.
October 6th 2021
Pregnant women infected with certain strains of human papillomavirus during pregnancy had a nearly fourfold greater risk of preterm labor.
September 3rd 2021
Human papillomavirus (HPV) impacts millions of Americans, and new study sought to address the epidemiology of HPV and high-grade squamous intraepithelial lesions (HSIL).
Understanding HPV Vaccine Hesitancy
The HPV vaccine is incredibly important in preventing certain cancers and a new study sought to address the safety concerns for vaccine refusal in a national immunization survey for teenagers.
HPV Vaccination Does Not Increase Risk of Syndromes with Autonomic Dysfunction
A new Danish study found no evidence of a causal association between the quadrivalent human papillomavirus vaccination and syndromes with autonomic dysfunction.
School STI Services Raise Complications of HIPAA Confidentiality
Clinicians accustomed to HIPAA guidelines may not be aware of changes in confidentiality when they make contact with school health care services.
Interviews Show Mixed HPV Knowledge Among Young MSM
A new study has identified that misinformation and limited clinician communication around HPV risk among young men who have sex with men some of the barriers to HPV vaccination.
Is 1 Dose Enough for HPV Vaccination?
A new retrospective study provides more evidence that a single HPV vaccine dose may be effective in preventing cervical cancer.
High Costs, Low Health Benefits Predicted for Extending HPV Vaccine
Vaccinating adults ages 27-45 years against human papillomavirus (HPV) was projected to have low public health benefits and high costs, according to a new report.
Home-Based Cervical Cancer Screening Kits Show Promise
Although screening and follow-up rates were lower than expected in this trial, the option of testing for HPV at home may prove to be a game-changer.
Lower Prevalence of Oral HPV Among Vaccinated Female Adolescents
A study of female adolescents at a health clinic in New York City has found the presence of HPV in the oral cavity is not uncommon, but the results also offer support for vaccination.
Study Demonstrates Long-Term Immunogenicity of 2-Dose HPV Vaccination Schedule
Long-term immunogenicity of a 2-dose schedule of the quadrivalent HPV vaccination was demonstrated in a new study in Canada that followed up on an earlier clinical trial.
Evidence of Herd Immunity to Oral HPV Infection Among Unvaccinated Men
A recent study found evidence of herd immunity to HPV oral infection among unvaccinated men aged 18 to 59 years in the United States.
Essential Vaccines by Age Group
As outbreaks of vaccine-preventable diseases grow, it is important to review vaccination recommendations by age group.
Australian Cohort Study: 1 Dose of HPV Vaccine as Effective as 2 or 3 Doses
The adjusted hazard ratios for 1-dose and 2-dose recipients were comparable to the 3-dose recipients (1 dose 1.01 [95%CI 0.81–1.26], 2 doses 1.00 [0.85–1.17]) after adjusting for age at vaccination among the vaccinated group.
Study: More Than 4 in 5 MSM on PrEP Have High-Risk HPV
Although PrEP drugs are key to preventing HIV infection, a new study by French investigators found a high prevalence of high-risk human papillomavirus infection among MSM taking PrEP.
CDC Committee Votes to Expand HPV Vaccine Recommendations for Men Up to Age 26
ACIP voted 10-to-4 to expand the recommended HPV vaccine “catch-up” age for men from 21 to 26, matching the existing guidelines for women.
Urinary HPV Testing May Be an Alternative to Pap Smear
Investigators on the CapU3 study concluded that urinary HPV testing may be a good alternative to Pap smear for some women.
Lower Levels of Cervical Cancer Rates Thanks to HPV Vaccine
The HPV vaccine appears to be doing what it was intended to do—lowering rates of cervical cancer, particularly HPV types 16 and 18, responsible for most cases worldwide.
HPV Vaccination Rates Fall Short in Adolescents
In 2016, 60% of adolescents had initiated the HPV vaccine series but only 16% completed the vaccination series by age 13 and 35% by age 15.
FDA Approves Expanded Use of HPV Vaccine to Older Populations
The recombinant 9-valent human papillomavirus (HPV) vaccine, Gardasil 9 is now approved in adults 27 to 45 years of age.
Carcinogenic HPV Type Has Highest Rate of Incidence and Lowest Rate of Clearance
When it comes to HPV infection in men who have sex with men, the type of virus they contract has real implications for their future cancer risk.
Quadrivalent HPV Catch-Up Vaccine Proves Effective in Women Under 21 Years
A new study reveals that the quadrivalent HPV catch-up vaccine was most effective against cancer risk in women who received the first dose between the ages of 14 and 20 years.
HPV Testing More Effective Than Pap Test at Detecting Cervical Intraepithelial Neoplasia
Study results suggest that HPV testing is able to detect cervical intraepithelial neoplasia earlier and more accurately than cytology.
HPV Vaccine May Reduce Risk of Severe Dysplasia
The women who received the HPV vaccine showed lower rates of severe dysplasia which can lead to cervical cancer.
Recurrence of HPV Types Found in Vaccine High Among Men with High-Risk Sexual Behavior
A higher number of new sexual partners, as well as lifetime sexual partners, may drive this risk in these patients.
United States Sees Drop in Rate of HPV Vaccination Course Completion
Despite public health recommendations, a new study has found that too many adolescents and young adults in the United States are failing to complete the full vaccination course for HPV.
HPV Vaccination Rates On the Rise Among US Males
While a new study has found that the HPV vaccination rate has more than tripled among young men in the United States, rates for both males and females are still well below public health targets.
Top Infectious Disease News of the Week—February 25, 2018
In case you missed them, we’ve compiled the top five infectious disease articles from this past week.
The Role of Dental Providers in Preventing HPV-Related Oral Cancer
A panel of experts in a recent symposium discuss how dental professionals can play an integral role in increasing HPV vaccination rates and decreasing HPV-related cancer.
FDA Approves HPV Test Capable of Identifying Cervical Cancer-Associated Genotypes
The FDA has granted pre-market approval for a new HPV test that can detect and identify HPV genotypes that put women at increased risk for cervical cancer.
ACIP Releases Updated Adult Immunization Schedule Recommendations
The CDC’s ACIP voted to approve updated adult immunization schedule recommendations for adults aged 19 years or older.
Investigators Find Large Survival Disparities Among Patients with HPV-Associated Cancers
A recent study finds that younger patients, women, and white individuals infected with HPV-associated cancers have superior survival at 5 years.
2 Clarke Drive Cranbury, NJ 08512